Titan Medical Inc

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Quantum International Corp. operates as an emerging robotics innovation company. It identifies and develops innovative products in the robotics, consumer electronics and lifestyle enhancement products. The company was founded on September 25, 2001 and is headquartered in Centennial, CO.

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that Cary G. Vance has been appointed as the company's President and CEO effective July 1, 2022. Mr. Vance will succeed Paul Cataford, Titan's chair of the board of directors, who has served as Interim President and CEO since December 2021.

Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") has notified the company that it has been granted an additional 180 calendar day period, through December 26, 2022, to evidence compliance with the US$1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market.

Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

De Novo marketing authorization planned for early 2025 remains unchanged De Novo marketing authorization planned for early 2025 remains unchanged

Titan Medical Provides Update to Enos Project Timeline

TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced its participation at this year's Society of Robotic Surgery (SRS) Annual Meeting.

Titan Medical to Participate at the Society of Robotic Surgery Annual Meeting

TORONTO, ON, June 21, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that it has signed an agreement with Nissha Medical Technologies for the manufacture of surgical consumables. These single-use surgical components will be used for verification and validation testing, and pre-clinical and clinical studies of Titan's Enos™ robotic single access surgical system.

Titan Medical Announces Agreement with Nissha Medical Technologies

TORONTO, June 09, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the voting results form the company's Annual and Special Meeting of its shareholders held on Wednesday June 8, 2022.

Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders

TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the appointment of Bill Fahey as Vice President, Manufacturing and Operations. In this new role, Mr. Fahey will be a key member of the senior leadership team and be responsible for both in-house and contract manufacturing relationships. He will also be working closely with Titan's product development and the quality and regulatory affairs teams as the company completes its Investigational Device Exemption (IDE) application and, following IDE approval, proceed to human clinical trials.

Titan Medical Appoints Bill Fahey as Vice President, Manufacturing and Operations

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced, after careful consideration and a review of the company's future needs, that Perry Genova, Senior Vice President of Research and Product Development, will depart the company effective immediately. “As we transform from a technology research and develo

Titan Medical Announces Executive Departure

Titan Medical Inc. (NASDAQ:TMDI ) Q1 2022 Results Conference Call May 12, 2022 8:30 AM ET Company Participants Kristen Galfetti - Vice President of Investor Relations Paul Cataford - Interim President & CEO Stephen Lemieux - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenhimer & Co Operator Good morning ladies and gentlemen. And welcome to the Titan Medical's First Quarter 2022 Financial Results Conference Call.

Titan Medical Inc. (TMDI) CEO Paul Cataford on Q1 2022 Results - Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three months ended March 31, 2022. “The entire team is focused on driving performance and progress supporting our IDE application submission milestone. We are also starting to prepare for the forthcoming commercialization of t

Titan Medical Reports Financial Results for the First Quarter 2022

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that its 2022 Annual and Special Meeting (“the Meeting”) is scheduled for Wednesday, June 8, 2022 at 4:00 p.m. ET to be held virtually at https://web.lumiagm.com/432237190. As described in the distributed proxy materials, shareholders are entitled to n

Titan Medical Announces Availability of Materials for the 2022 Annual and Special Meeting of Shareholders

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced receipt of a $2.6 million purchase order from Medtronic plc (NYSE: MDT), a global leader in healthcare technology. The order covers the purchase of instruments and cameras that will be used in preclinical activities and the evaluation of Titan Medical

Titan Medical Announces Purchase Order from Medtronic

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its first quarter 2022 financial results prior to market opening on Thursday, May 12, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights. Speakers will include Paul Cataford, Interim President and Chief Executi

Titan Medical to Issue First Quarter 2022 Financial Results on May 12, 2022

TORONTO--(BUSINESS WIRE)--Titan Medical to Present at the Bloom Burton & Co. Healthcare Investor Conference

Titan Medical to Present at the Bloom Burton & Co. Healthcare Investor Conference

Titan Medical Inc. (TMDI) CEO Paul Cataford on Q4 2021 Results - Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2021

Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2021

TORONTO--(BUSINESS WIRE)--Titan Medical to Report Year End 2021 Financial Results on March 24, 2022

Titan Medical to Report Year End 2021 Financial Results on March 24, 2022

TORONTO--(BUSINESS WIRE)--Titan Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference

Titan Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference

Titan Medical Inc. (TMDI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Titan Medical Inc. (TMDI) to Report a Decline in Earnings: What to Look Out for

TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced that it has surpassed 200 patents and patent applications. This important milestone demonstrates the company's commitment to being an innovation leader in single access robotic-assisted surgery. This broad portfolio protects the company's proprietary t

Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy

Berkshire Grey

Intuitive Surgical

Luminar Technologies

Ouster, Inc

Vicarious Surgical

Trimble

Velodyne Lidar

Zebra Technologies

December 2021 saw investments in robotics of roughly USD1.2bn. The lion's share of the funding in went to autonomous driving companies.

Robotics Investments In December 2021

TORONTO--(BUSINESS WIRE)--Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic

Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic

Benchmark Electronics

TORONTO--(BUSINESS WIRE)--Titan Medical Selects Benchmark to Manufacture Enos Robotic Single Access Surgical System

Titan Medical Selects Benchmark to Manufacture Enos Robotic Single Access Surgical System

TORONTO--(BUSINESS WIRE)--Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference

Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference

Medtronic

TORONTO--(BUSINESS WIRE)--Titan Medical Completes Final Milestone under Development Agreement with Medtronic

News for Titan Medical Inc Stock (TMDI)